ABVC BioPharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ABVC BioPharma, Inc. (ABVC) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $302.30 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $302.30K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $331.50K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $366.98K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.32K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $302.30K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $331.50K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $366.98K 10-K · filed 2026-03-03 |
| 2025-09-30 | $9.32K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $13.52K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $13.56K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $15.39K 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.27K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.90K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.71K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $3.73K 10-K · filed 2024-03-13 |
| 2023-09-30 | $4.81K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $6.18K 10-Q · filed 2023-08-14 |